Investor Overview


Corporate Profile

Synta Pharmaceuticals is an innovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients. ... 


NASDAQ | SNTA (Common)
$0.38 (2.70%) + 0.01
Stock chart for: SNTA.O.  Currently trading at $0.38 with a 52 week high of $2.65 and a 52 week low of $0.15.
May 25, 2016 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.